Gene therapy has experienced an increasing number of successful human clinical trials, leading to numerous FDA-approved therapies based on recombinant viruses for rare disease, cancer, and other ...

Gene therapy represents one of medicine’s most ambitious attempts to treat disease at its root cause by altering the genetic code itself. The approach works by recovering the functions of critical ...

A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks ...

For generations, Sickle Cell Disease has been a devastating illness affecting millions of people around the world, ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

Summary: Researchers demonstrated that an experimental, systemic gene therapy can shield the central nervous system from the devastating cognitive decline and structural damage caused by ...

The agreement is set to expand LEO Pharma’s pipeline in rare dermatology.

Gene therapy achieved its first major breakthroughs in the early 1990s with the treatment of a rare disease called severe combined immunodeficiency. However, the field was dealt a serious setback in ...

The idea behind intra-articular gene therapy for treating osteoarthritis (OA) is to deliver the gene-altering vector or cells directly to the precise site of the disease with a single injection — so ...